[Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)].
Jan Paul Ottervanger, Patricia M. L. A. van den Bemt, G H de Koning, Bruno H. Stricker
Abstract
Jan Paul Ottervanger, Patricia M. L. A. van den Bemt, G H de Koning, Bruno H. Stricker
Abstract
Fluoxetine (Prozac) and fluvoxamine (Fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. Since these drugs block serotonin reuptake in platelets also, they might under certain conditions lead to clinically significant platelet dysfunction. Four patients are described who developed bleeding during treatment with either fluoxetine or fluvoxamine.
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Fluoxetine (Prozac) and fluvoxamine (Fevarin) are nontricyclic serotonin (5-hydroxytryptamine) reuptake inhibitors prescribed for the treatment of depression. Since these drugs block serotonin reuptake in platelets also, they might under certain conditions lead to clinically significant platelet dysfunction. Four patients are described who developed bleeding during treatment with either fluoxetine or fluvoxamine.
Key concepts: Fluvoxamine, Fluoxetine, Medicine, Serotonin reuptake inhibitor, Reuptake inhibitor, Serotonin, Pharmacology, Paroxetine